277 related articles for article (PubMed ID: 27331023)
1. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Shimanovsky A; Alvarez Argote J; Murali S; Dasanu CA
BBA Clin; 2016 Dec; 6():12-8. PubMed ID: 27331023
[TBL] [Abstract][Full Text] [Related]
2. Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.
McShane CM; Murray LJ; Landgren O; O'Rorke MA; Korde N; Kunzmann AT; Ismail MR; Anderson LA
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):332-42. PubMed ID: 24451437
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance.
Sigurbergsdóttir AÝ; Love TJ; Kristinsson SY
Front Immunol; 2022; 13():876271. PubMed ID: 35572590
[TBL] [Abstract][Full Text] [Related]
5. History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study.
Lindqvist EK; Landgren O; Lund SH; Turesson I; Hultcrantz M; Goldin L; Björkholm M; Kristinsson SY
Ann Hematol; 2017 Feb; 96(2):261-269. PubMed ID: 27807648
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
7. Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Sverrisdottir I; Thorsteinsdottir S; Rognvaldsson S; Aspelund T; Vidarsson B; Onundarson PT; Agnarsson BA; Sigurdardottir M; Thorsteinsdóttir I; Sveinsdottir SV; Palmason R; Olafsson I; Sigurdsson F; Thordardóttir AR; Eythorsson E; Jonsson A; Palsson R; Indridason OS; Gislason GK; Olafsson A; Sigurdsson J; Steingrímsdóttir H; Einarsson Long T; Hultcrantz M; Durie BGM; Harding S; Landgren O; Kristinsson SY; Love TJ
Ann Intern Med; 2024 Jun; 177(6):711-718. PubMed ID: 38768457
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
Baldursdóttir TR; Löve ÞJ; Gíslason GK; Björkholm M; Mellqvist UH; Lund SH; Blimark CH; Turesson I; Hultcrantz M; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Mar; 106(3):380-388. PubMed ID: 33295006
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
Castaneda-Avila MA; Ulbricht CM; Epstein MM
Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
11. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
van de Donk NW; Mutis T; Poddighe PJ; Lokhorst HM; Zweegman S
Int J Lab Hematol; 2016 May; 38 Suppl 1():110-22. PubMed ID: 27161311
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy: The good, the bad and the ugly.
Glavey SV; Leung N
Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
[TBL] [Abstract][Full Text] [Related]
16. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis.
Gámez B; Edwards CM
Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
18. Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins.
Bosseboeuf A; Allain-Maillet S; Mennesson N; Tallet A; Rossi C; Garderet L; Caillot D; Moreau P; Piver E; Girodon F; Perreault H; Brouard S; Nicot A; Bigot-Corbel E; Hermouet S; Harb J
Front Immunol; 2017; 8():1347. PubMed ID: 29098000
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
Stelmach-Gołdyś A; Czarkowska-Paczek B
Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
[TBL] [Abstract][Full Text] [Related]
20. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
